1. Home
  2. BJDX vs SPRC Comparison

BJDX vs SPRC Comparison

Compare BJDX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$1.83

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$3.61

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BJDX
SPRC
Founded
2015
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
2.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BJDX
SPRC
Price
$1.83
$3.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.0K
48.1K
Earning Date
05-12-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
86.65
N/A
EPS
N/A
N/A
Revenue
$249,040.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.23
52 Week High
$10.20
$8.90

Technical Indicators

Market Signals
Indicator
BJDX
SPRC
Relative Strength Index (RSI) 49.44 50.42
Support Level $1.75 $3.23
Resistance Level $2.08 $4.85
Average True Range (ATR) 0.16 0.33
MACD -0.00 -0.23
Stochastic Oscillator 65.29 12.64

Price Performance

Historical Comparison
BJDX
SPRC

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: